Ureaplasma, bronchopulmonary dysplasia, and azithromycin in European neonatal intensive care units

A survey

Claudia Pansieri, Chiara Pandolfini, Valery Elie, Mark A. Turner, Sailesh Kotecha, Evelyne Jacqz-Aigrain, Maurizio Bonati

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

A survey was set up to gauge the opinions of neonatologists on the role of Ureaplasma in bronchopulmonary dysplasia (BPD) development, the use of azithromycin for BPD prevention, and the factors influencing azithromycin use in European neonatal intensive care units (NICUs). 167 NICUs participated in the survey, representing 28 European countries. For respondents, the two major perceived risk factors for BPD were prematurity of

Original languageEnglish
Article number4076
JournalScientific Reports
Volume4
DOIs
Publication statusPublished - Feb 12 2014

Fingerprint

Ureaplasma
Bronchopulmonary Dysplasia
Azithromycin
Neonatal Intensive Care Units
Surveys and Questionnaires

ASJC Scopus subject areas

  • General
  • Medicine(all)

Cite this

Ureaplasma, bronchopulmonary dysplasia, and azithromycin in European neonatal intensive care units : A survey. / Pansieri, Claudia; Pandolfini, Chiara; Elie, Valery; Turner, Mark A.; Kotecha, Sailesh; Jacqz-Aigrain, Evelyne; Bonati, Maurizio.

In: Scientific Reports, Vol. 4, 4076, 12.02.2014.

Research output: Contribution to journalArticle

Pansieri, Claudia ; Pandolfini, Chiara ; Elie, Valery ; Turner, Mark A. ; Kotecha, Sailesh ; Jacqz-Aigrain, Evelyne ; Bonati, Maurizio. / Ureaplasma, bronchopulmonary dysplasia, and azithromycin in European neonatal intensive care units : A survey. In: Scientific Reports. 2014 ; Vol. 4.
@article{6151e707ceda4c62bc442d20995ce5b3,
title = "Ureaplasma, bronchopulmonary dysplasia, and azithromycin in European neonatal intensive care units: A survey",
abstract = "A survey was set up to gauge the opinions of neonatologists on the role of Ureaplasma in bronchopulmonary dysplasia (BPD) development, the use of azithromycin for BPD prevention, and the factors influencing azithromycin use in European neonatal intensive care units (NICUs). 167 NICUs participated in the survey, representing 28 European countries. For respondents, the two major perceived risk factors for BPD were prematurity of",
author = "Claudia Pansieri and Chiara Pandolfini and Valery Elie and Turner, {Mark A.} and Sailesh Kotecha and Evelyne Jacqz-Aigrain and Maurizio Bonati",
year = "2014",
month = "2",
day = "12",
doi = "10.1038/srep04076",
language = "English",
volume = "4",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Ureaplasma, bronchopulmonary dysplasia, and azithromycin in European neonatal intensive care units

T2 - A survey

AU - Pansieri, Claudia

AU - Pandolfini, Chiara

AU - Elie, Valery

AU - Turner, Mark A.

AU - Kotecha, Sailesh

AU - Jacqz-Aigrain, Evelyne

AU - Bonati, Maurizio

PY - 2014/2/12

Y1 - 2014/2/12

N2 - A survey was set up to gauge the opinions of neonatologists on the role of Ureaplasma in bronchopulmonary dysplasia (BPD) development, the use of azithromycin for BPD prevention, and the factors influencing azithromycin use in European neonatal intensive care units (NICUs). 167 NICUs participated in the survey, representing 28 European countries. For respondents, the two major perceived risk factors for BPD were prematurity of

AB - A survey was set up to gauge the opinions of neonatologists on the role of Ureaplasma in bronchopulmonary dysplasia (BPD) development, the use of azithromycin for BPD prevention, and the factors influencing azithromycin use in European neonatal intensive care units (NICUs). 167 NICUs participated in the survey, representing 28 European countries. For respondents, the two major perceived risk factors for BPD were prematurity of

UR - http://www.scopus.com/inward/record.url?scp=84894206929&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894206929&partnerID=8YFLogxK

U2 - 10.1038/srep04076

DO - 10.1038/srep04076

M3 - Article

VL - 4

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 4076

ER -